What was this study?
The Libertas Integrative Lyme Disease Study summary describes eight patients receiving integrative care for Lyme disease and related co-infections over three to six months during 2025–2026.
Participants were evaluated at baseline and follow-up. This was an observational study of a care program, not a randomized comparison isolating MineralsRx.
- Participants
- 8
- Follow-up period
- 3–6 months
- Study type
- Observational
- Dates in source title
- 2025–2026
What was measured?
The summary groups assessments into three areas: infection-related findings, overall system stress and immune or inflammatory activity. It refers to laboratory testing, pathogen panels, full-systems evaluations and energetic assessments.
Laboratory measurements and energetic assessments are different types of information. The summary does not supply the complete underlying measurements needed to independently verify every outcome category.
As reported in the supplied summary
What did the summary report?
| Reported category | Participants |
|---|---|
| Pathogen reduction or clearance | 8 of 8 |
| System-wide improvement | 6 of 8 |
| Improved immune regulation | 7 of 8 |
Read these counts in context
These are the summary’s reported classifications. They are not a verified product cure rate or a measurement of the effect of MineralsRx alone. The available summary does not provide the full assay results, endpoint definitions or statistical analysis behind these counts.
The source also describes different individual patterns over follow-up. Its interpretations of those patterns should not be treated as established biological mechanisms.
What can we conclude?
The observations describe changes during integrative care in a small group. They may inform further questions, but concurrent treatment, the small sample and the absence of a reported randomized control group limit what can be concluded.
- The independent contribution of MineralsRx is not established by this summary.
- Reported classifications are not a substitute for original laboratory values and methods.
- The findings do not establish outcomes for the new MineralsRx Cream.
- An individual’s results may differ from the patterns described.